Stephanie Okey
Director/Board Member at PTC THERAPEUTICS, INC.
Net worth: 437 293 $ as of 2024-04-29
Stephanie Okey active positions
Companies | Position | Start | End |
---|---|---|---|
PTC THERAPEUTICS, INC. | Director/Board Member | 2018-12-17 | - |
Independent Dir/Board Member | 2018-12-17 | - | |
CRINETICS PHARMACEUTICALS, INC. | Director/Board Member | 2019-07-14 | - |
Independent Dir/Board Member | 2019-07-14 | - | |
CATALENT, INC. | Director/Board Member | 2023-08-28 | - |
Independent Dir/Board Member | 2023-08-28 | - |
Career history of Stephanie Okey
Former positions of Stephanie Okey
Companies | Position | Start | End |
---|---|---|---|
ALBIREO PHARMA, INC. | Director/Board Member | 2018-06-07 | 2023-03-01 |
Independent Dir/Board Member | 2018-06-07 | 2023-03-01 | |
ORPHAZYME A/S | Director/Board Member | 2021-03-24 | 2022-05-22 |
California Life Sciences Association
California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | Director/Board Member | 2014-09-30 | 2015-12-31 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 1986-12-31 | 2015-06-30 |
Training of Stephanie Okey
The Ohio State University | Undergraduate Degree |
Wright State University (Ohio) | Graduate Degree |
Statistics
International
United States | 9 |
Denmark | 2 |
Operational
Director/Board Member | 6 |
Independent Dir/Board Member | 4 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 7 |
Consumer Services | 3 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 4 |
---|---|
PTC THERAPEUTICS, INC. | Health Technology |
CRINETICS PHARMACEUTICALS, INC. | Health Technology |
ORPHAZYME A/S | Health Technology |
CATALENT, INC. | Health Technology |
Private companies | 3 |
---|---|
Albireo Pharma, Inc.
Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
California Life Sciences Association
California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | Commercial Services |
- Stock Market
- Insiders
- Stephanie Okey
- Experience